(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2...re to be used in clinical trials ... July 29 The Lions Clubs of Multiple,District 5M ... Spring Point,Project, a Minnesota non-profit orga...despread availability of pig donors of islet tissu...com/cgi-bin/prnh/20071214/CLF057LOGO-b ), Spring...
...Innovations, Inc. (Amex: IMA ), a global leader i...nnounced its financial results for the quarter,end... the Company recorded net revenue of,$401.1 millio... second,quarter of 2007. The revenue increase was ...enue in our Professional Diagnostics segment which...
...ng stem cell technology to an,orphan disease, in a..., Mass. and IRVINE, Calif., July 29 ,ALS Therapy D... Cell, Inc.,(CSC) announced today a new collaborat...f stem cells in treating ALS - amyotrophic lateral.... The new set of experiments will,begin in August ...
Other Biology Technology:Spring Point Project Gains Support of Lions Clubs 2Spring Point Project Gains Support of Lions Clubs 3Inverness Medical Innovations Announces Second Quarter 2008 Results 2Inverness Medical Innovations Announces Second Quarter 2008 Results 3Inverness Medical Innovations Announces Second Quarter 2008 Results 4Inverness Medical Innovations Announces Second Quarter 2008 Results 5Inverness Medical Innovations Announces Second Quarter 2008 Results 6Inverness Medical Innovations Announces Second Quarter 2008 Results 7Inverness Medical Innovations Announces Second Quarter 2008 Results 8Inverness Medical Innovations Announces Second Quarter 2008 Results 9Inverness Medical Innovations Announces Second Quarter 2008 Results 10Inverness Medical Innovations Announces Second Quarter 2008 Results 11Inverness Medical Innovations Announces Second Quarter 2008 Results 12Inverness Medical Innovations Announces Second Quarter 2008 Results 13Inverness Medical Innovations Announces Second Quarter 2008 Results 14Inverness Medical Innovations Announces Second Quarter 2008 Results 15Inverness Medical Innovations Announces Second Quarter 2008 Results 16ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration 2ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration 3LabFax: Immunochemistry from Promega
Sheep Growth Hormone from Cell Sciences
Bovine Albumin from Bovine Serum, Unconjugated from Molecular Probes (Invitrogen)
Dynabeads Epithelial Enrich from Dynal Biotech
Biology Products: